The Evolving Treatment Landscape in Light Chain Amyloidosis with Cardiac Involvement

Expert oncologists discuss the current treatment landscape and latest data in the treatment of patients with AL amyloidosis with cardiac involvement.

EP. 1: AL Amyloidosis: Background, Patient Profile, and Staging

December 20th 2023

Expert oncologists Dr. Jeffrey Zonder and Dr. Shaji Kumar discuss AL amyloidosis background, typical patient profiles, and disease staging and risk stratification.

EP. 2: Navigating the Differential Diagnosis of AL Amyloidosis

December 20th 2023

Dr. Kumar discusses best practices for accurately and prompt diagnosing AL amyloidosis as well as navigating differential diagnosis.

EP. 3: Treatment Approaches in AL Amyloidosis

January 8th 2024

Dr. Zonder discusses the current treatment landscape in AL amyloidosis, highlighting recent advances.

EP. 4: Limitations of Available Treatment Options for Patients with Cardiac Involvement

January 8th 2024

Expert oncologist Dr. Kumar provides his assessment of unmet needs in AL Amyloidosis, particularly patients with cardiac involvement.

EP. 5: Birtamimab in AL Amyloidosis: Key Takeaways from the Phase III VITAL Trial

January 8th 2024

Drs. Kumar and Zonder discuss results from the Phase III Vital trial investigating birtamimab and key takeaways.

EP. 6: Birtamimab Safety Profile in the VITAL Study

January 8th 2024

Dr. Zonder discusses the safety profile of birtamimab in the VITAL study and the clinical implications.

EP. 7: Adverse Event Management in AL Amyloidosis

January 15th 2024

Dr. Kumar discusses strategies for managing adverse events in patients with AL amyloidosis.

EP. 8: Ongoing AFFIRM-AL Trial Background, Patient Eligibility, and Active Enrollment

January 15th 2024

Dr. Kumar and Dr. Zonder discuss the ongoing confirmatory Phase III AFFIRM-AL trial investigating the efficacy and safety of birtamimab and ongoing recruitment in the trial.

EP. 9: Revolutionizing the AL Amyloidosis Treatment Paradigm: Novel Agents and Combination Approaches

January 22nd 2024

Expert oncologists discuss the progression treatment landscape in AL amyloidosis and agents of investigation.

EP. 10: Clinical Pearls and Future Directions in AL Amyloidosis

January 22nd 2024

Dr. Zonder and Dr. Kumar share their clinical pearls and perspectives on future directions in the treatment of AL amyloidosis.